These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30639825)

  • 1. Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
    King AA; McKinstry RC; Wu J; Eapen M; Abel R; Varughese T; Kamani N; Shenoy S
    Biol Blood Marrow Transplant; 2019 May; 25(5):e174-e178. PubMed ID: 30639825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
    Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
    Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Aslam HM; Yousuf S; Kassim A; Iqbal SM; Hashmi SK
    Bone Marrow Transplant; 2018 Nov; 53(11):1390-1400. PubMed ID: 29728697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.
    Green NS; Bhatia M; Griffith EY; Qureshi M; Briamonte C; Savone M; Sands S; Lee MT; Lignelli A; Brickman AM
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):670-676. PubMed ID: 28089760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.
    Stenger E; Xiang Y; Wetzel M; Gillespie S; Chellapandian D; Shah R; Arnold SD; Bhatia M; Chaudhury S; Eckrich MJ; Kanter J; Kasow KA; Krajewski J; Nickel RS; Ngwube AI; Olson TS; Rangarajan HG; Wobma H; Guilcher GMT; Horan JT; Krishnamurti L; Shenoy S; Abraham A
    Transplant Cell Ther; 2023 Jan; 29(1):47.e1-47.e10. PubMed ID: 36273784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
    Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Walters MC; De Castro LM; Sullivan KM; Krishnamurti L; Kamani N; Bredeson C; Neuberg D; Hassell KL; Farnia S; Campbell A; Petersdorf E
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):207-211. PubMed ID: 26500093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.
    George SA; Veludhandi A; Xiang Y; Liu K; Stenger E; Arnold SD; Mehta A; Schirmer DA; Spencer JB; Guilcher GMT; Bhatia M; Abraham A; Gomez-Lobo V; Krishnamurti L; Meacham LR
    Transplant Cell Ther; 2024 Sep; 30(9):912.e1-912.e13. PubMed ID: 38972510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease.
    Rangarajan HG; Abu-Arja R; Pai V; Guilcher GMT; Soni S
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):413-417. PubMed ID: 29061531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation.
    Bernaudin F; Verlhac S; Fréard F; Roudot-Thoraval F; Benkerrou M; Thuret I; Mardini R; Vannier JP; Ploix E; Romero M; Cassé-Perrot C; Helly M; Gillard E; Sebag G; Kchouk H; Pracros JP; Finck B; Dacher JN; Ickowicz V; Raybaud C; Poncet M; Lesprit E; Reinert PH; Brugières P
    J Child Neurol; 2000 May; 15(5):333-43. PubMed ID: 10830200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
    Krishnamurti L; Kharbanda S; Biernacki MA; Zhang W; Baker KS; Wagner JE; Wu CJ
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1270-8. PubMed ID: 18940682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed donor chimerism following stem cell transplantation for sickle cell disease.
    Shah NC; Rangarajan HG; Ngwube A; Shenoy S
    Curr Opin Hematol; 2023 Nov; 30(6):187-193. PubMed ID: 37694765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation.
    Monagel DA; Guilcher GMT; Nettel-Aguirre A; Bendiak GN
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29927. PubMed ID: 35927947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.
    Bhatia M; Kolva E; Cimini L; Jin Z; Satwani P; Savone M; George D; Garvin J; Paz ML; Briamonte C; Cruz-Arrieta E; Sands S
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):666-72. PubMed ID: 25559691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease.
    Bakshi N; Astles R; Chou E; Hurreh A; Sil S; Sinha CB; Sanders KA; Peddineni M; Gillespie SE; Keesari R; Krishnamurti L
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30046. PubMed ID: 36322607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has stem cell transplantation come of age in the treatment of sickle cell disease?
    Shenoy S
    Bone Marrow Transplant; 2007 Nov; 40(9):813-21. PubMed ID: 17704797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.